Retinoic acid and methotrexate specifically increase PHA‐E‐lectin binding to a 67‐kDa glycoprotein in LA‐N‐1 human neuroblastoma cells

Sharon A. Ross, Carol S. Jones, Luigi M. De Luca

Research output: Contribution to journalArticle

Abstract

Retinoic acid (RA) decreased growth and increased morphologic differentiation of human neuroblastoma LA‐N‐1 cells. These phenomena correlated with a specific enhancement of PHA‐E lectin binging to a glycoprotein of MW 67 kDa (gp67). Gp67 was found susceptible to N‐glycanase and displayed BSA binding by affinity chromatography analysis. The chemotherapeutic agent methotrexate (MTX) also reduced growth and induce differentiation of LA‐N‐1 cells. In addition, the cells responded to MTX as well as to doxorubicin by a marked increase in PHA‐E binding to gp67. We conclude that reduced growth and induction of morphological differentiation of LA‐N‐1 cells correlated with increased binding of PHA‐E to gp67. © 1995 Wiley‐Liss Inc.

Original languageEnglish (US)
Pages (from-to)303-308
Number of pages6
JournalInternational Journal of Cancer
Volume62
Issue number3
DOIs
StatePublished - Jul 28 1995
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Retinoic acid and methotrexate specifically increase PHA‐E‐lectin binding to a 67‐kDa glycoprotein in LA‐N‐1 human neuroblastoma cells'. Together they form a unique fingerprint.

  • Cite this